MKMasato Kitazawa

Masato Kitazawa

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Masato Kitazawa has a total of 95 co-authors. Here are the top co-authors by number of shared publications:

  • Yuji Soejima

    Division of Gastroenterological, Hepato-Biliary-Pancreatic, Transplantation and Pediatric Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Nagano, Japan

    22 shared publications
  • Satoshi Nakamura

    Division of Gastroenterological, Hepato-Biliary-Pancreatic, Transplantation and Pediatric Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Nagano, Japan

    21 shared publications
  • Yuta Yamamoto

    Division of Gastroenterological, Hepato-Biliary-Pancreatic, Transplantation and Pediatric Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Nagano, Japan

    18 shared publications
  • Nao Hondo

    Division of Gastroenterological, Hepato-Biliary-Pancreatic, Transplantation and Pediatric Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Nagano, Japan

    17 shared publications
  • Satoru Miyazaki

    Division of Gastroenterological, Hepato-Biliary-Pancreatic, Transplantation and Pediatric Surgery, Department of Surgery, Shinshu University School of Medicine, Matsumoto, Nagano, Japan

    16 shared publications
  • Makoto Koyama

    Division of Gastroenterological, Hepato‐Biliary‐Pancreatic, Transplantation and Pediatric Surgery, Department of Surgery Shinshu University School of Medicine Matsumoto Japan

    14 shared publications

Latest Publications

  • Open Access

    Dual targeting of SOS1 and EGFR suppresses growth of KRAS-mutant colorectal cancer

    by Hirokazu Tanaka, Masato Kitazawa, Satoshi Nakamura, Yuta Yamamoto, Satoru Miyazaki, Nao Hondo, Masatsugu Kuroiwa, Dai Kimura, Shiori Yamazaki, Masahiro Kataoka, et al.

    KRAS mutations are major oncogenic drivers in colorectal cancer (CRC), but effective targeted therapies remain limited. Son of sevenless homolog 1 (SOS1), a guanine nucleotide exchange factor regulating KRAS activation, is a promising therapeutic target. We evaluated the antitumor effects of the SOS1 inhibitor BI-3406 alone and combined with cetuximab in KRAS-mutant CRC models, including KRAS inhibitor-resistant cells. Endogenous KRAS-mutant CRC cell lines and KRAS-transduced Caco-2 cells harboring G12D, G12V, or G13D mutations were treated with BI-3406, cetuximab, or both. Cell proliferation and intracellular signaling were assessed by Cell Counting Kit-8 assay and western blotting, respectively. In vivo efficacy was examined using xenograft models. BI-3406-resistant and MRTX1133-resistant KRAS G12D-mutant cells were also established to assess cross-resistance. BI-3406 inhibited cell proliferation dose-dependently and transiently suppressed ERK phosphorylation, followed by ERK reactivation. Combined BI-3406 and cetuximab enhanced antiproliferative activity and sustained ERK suppression compared with either monotherapy. In xenografts, the combination significantly inhibited tumor growth, reduced Ki-67 expression, and increased apoptosis. BI-3406 remained active in MRTX1133-resistant cells, whereas MRTX1133 retained activity in BI-3406-resistant cells, indicating limited cross-resistance. These findings suggest that combining SOS1 inhibition with EGFR blockade is a promising strategy for KRAS-mutant CRC and that SOS1 inhibition may provide an alternative approach after resistance to selective KRAS-targeted therapies.

  • Open Access

    The Correlation of PBK Expression with an Immune-Activated Tumor Microenvironment and Outcome in Colorectal Cancer

    by Hiroshi Sawaguchi, Takeshi Uehara, Mai Iwaya, Shiho Asaka, Tomoyuki Nakajima, Shotaro Komamura, Shunsuke Imamura, Yugo Iwaya, Shinsuke Sugenoya, Masato Kitazawa, et al.

    Background/Objectives: PDZ-binding kinase (PBK) regulates mitosis, but its clinical significance and cellular localization in colorectal cancer (CRC) remain unclear. We evaluated PBK expression in CRC tissues and examined its association with clinicopathological features, immune contexture, and outcomes. Methods: PBK expression was assessed by RNA in situ hybridization in tumors from 246 CRC patients. Associations with TNM stage, vascular invasion, MMR status (dMMR/pMMR), immune cell infiltration, and stromal programmed death-ligand 1 (PD-L1) were analyzed. Overall survival (OS) and recurrence-free survival (RFS) were evaluated using Kaplan–Meier and Cox models. Public single-cell RNA sequencing datasets were analyzed to identify PBK-expressing cell populations. Results: Among 246 cases, 75 (30.5%) showed high PBK expression. High PBK expression was associated with lower TNM stage, absence of vascular invasion, and dMMR status. High-PBK tumors showed an immune-activated microenvironment, including increased CD4+, CD8+, and FOXP3+ T-cell infiltration, higher stromal PD-L1 expression, and higher tumor-infiltrating lymphocyte scores. Single-cell analysis indicated that PBK expression was enriched mainly in proliferative tumor epithelial cell populations. High PBK expression was associated with longer OS and RFS and remained an independent favorable prognostic factor in multivariate analysis. Conclusions: PBK expression in CRC is linked to proliferative tumor epithelial states, an immune-activated microenvironment, and favorable outcomes, supporting its utility as a prognostic biomarker.


  • Open Access

    Megacolon Associated with Multiple Endocrine Neoplasia Type 2B: A Case Successfully Managed with Ileostomy

    by Takeshi Ikeda, Nao Hondo, Masato Kitazawa, Satoshi Nakamura, Yuta Yamamoto, Satoru Miyazaki, Masahiro Kataoka, Hirokazu Tanaka, Naoki Ishizaka, Tadaaki Shimizu, et al.

    INTRODUCTION: Multiple endocrine neoplasia type 2B (MEN2B) is a rare genetic disorder characterized by medullary thyroid carcinoma, pheochromocytoma, mucosal neuromas, and Marfanoid body habitus. Megacolon is a common non-endocrine manifestation, with approximately 75% of patients experiencing gastrointestinal symptoms, such as constipation or diarrhea, often as early clinical signs. Although these symptoms may be important diagnostic signs, there are currently no distinct therapeutic guidelines. Here, we report a case of MEN2B-associated megacolon that was managed surgically, resulting in a favorable outcome.CASE PRESENTATION: A 23-year-old man with a history of chronic constipation was diagnosed with MEN2B at 14 years of age based on findings of medullary thyroid carcinoma, mucosal neuromas, and rectal biopsy-confirmed intestinal ganglioneuromatosis. He previously underwent total thyroidectomy and emergency transverse colectomy for volvulus. Progressive colonic dilatation led to abdominal distension and organ compression, prompting referral. Imaging confirmed marked colonic dilation. Laparoscopic subtotal colectomy with ileosigmoid anastomosis was performed. Postoperatively, the patient experienced recurrent ileus and required hospital readmission for small bowel obstruction. Two months postoperatively, the patient presented with a gastrointestinal perforation at the anastomotic site and underwent resection with terminal ileostomy. The postoperative course was uneventful, and the patient remained symptom-free.CONCLUSIONS: MEN2B-associated megacolon results from diffuse intestinal ganglioneuromatosis. Considering its progressive and extensive nature, decompression via stoma creation may be necessary to improve the postoperative outcomes and reduce the risk of symptom recurrence. Increased awareness and individualized surgical planning are crucial for treating this rare but serious complication of MEN2B.

  • Open Access

    A Case with a Pathological Course Resembling Ulcerative Colitis after Rectal Cancer Surgery with Diversion

    by Tadaaki Shimizu, Masato Kitazawa, Atsuhiro Hirayama, Satoshi Nakamura, Yuta Yamamoto, Satoru Miyazaki, Nao Hondo, Masahiro Kataoka, Hirokazu Tanaka, Masatsugu Kuroiwa, et al.

    INTRODUCTION: The development of de novo ulcerative colitis (UC) is rare after colorectal cancer surgery. In contrast, diversion colitis is a common inflammatory condition of the defunctionalized colon following stoma creation, often complicating postoperative diagnosis.CASE PRESENTATION: A 49-year-old man with advanced rectal cancer was treated with neoadjuvant chemotherapy followed by robot-assisted ultra-low anterior resection with diverting stoma. His postoperative course was complicated by an anastomotic leak. During the diversion period, he developed fever, diarrhea, and colonic inflammation that was initially diagnosed as diversion colitis and responded dramatically to systemic steroid therapy. Following stoma closure, recurrent anastomotic ulceration and diffuse colitis developed, again showing marked steroid responsiveness. Based on the overall clinical course, the patient was considered to have a clinical course resembling UC rather than diversion colitis. The patient achieved sustained remission with systemic steroids and mesalamine, with no recurrence of intestinal inflammation or cancer.CONCLUSIONS: This case underscores the challenges in distinguishing UC from diversion colitis in the postoperative setting. Recurrent anastomotic inflammation with pronounced steroid responsiveness should prompt consideration of underlying UC, even after colorectal cancer surgery.

  • High Incidence of Asymptomatic Pulmonary Embolism Detected on Early Postoperative CT After Thoracoscopic Esophagectomy for Esophageal Cancer: A Prospective Observational Study

    by Satoshi Nakamura, Masato Kitazawa, Yuta Yamamoto, Satoru Miyazaki, Nao Hondo, Masahiro Kataoka, Hirokazu Tanaka, Naoki Ishizaka, Tadaaki Shimizu, Yuji Soejima

    Background/Aim: Thoracoscopic esophagectomy for esophageal cancer remains highly invasive, with venous thromboembolism (VTE) representing a serious postoperative complication. The early post-operative incidence and clinical significance of asymptomatic pulmonary embolism (PE) remain poorly defined. Patients and Methods: This single-center prospective study enrolled 57 patients who underwent thoracoscopic esophagectomies for esophageal or esophagogastric junction cancer between May 2020 and October 2024. Contrast-enhanced computed tomography (CT) was routinely performed on postoperative day (POD) 3 to detect PE and deep vein thrombosis. Clinical, surgical, and laboratory parameters, including coagulation markers and inflammatory indices, were analyzed to identify the potential risk factors. Results: Postoperative thrombotic events were observed in 70% (n=40) of the patients. Asymptomatic PE was detected in 24.6% (n=14) of patients and azygos arch stump thrombosis in 43.9% (n=25). A higher preoperative platelet-to-lymphocyte ratio and elevated soluble fibrin levels on POD 1 were associated with VTE, although multivariate analysis did not identify any independent predictors of PE. Most thrombi resolved with anticoagulant therapy without severe complications. Conclusion: Routine POD 3 CT revealed a high incidence of asymptomatic PE following thoracoscopic esophagectomy. Given the limited predictive utility of conventional markers, early postoperative imaging or tailored prophylactic anticoagulation should be considered to mitigate the thromboembolic risk.


  • Open Access

    The Clinical Outcomes of Preoperative Self‐Expandable Metal Stent Placement as Bridge to Surgery for Obstructive Colorectal Cancer

    by Ryosuke Aoki, Nao Hondo, Masato Kitazawa, Satoshi Nakamura, Makoto Koyama, Masahiro Kataoka, Hirokazu Tanaka, Takuya Iguchi, Yonghan Park, Yuji Soejima

    Background: Self‐expandable metal stent (SEMS) placement for obstructive colorectal cancer (OCRC) is widely performed as a bridge to surgery because of its lower mortality rate than emergency surgery. However, the long‐term outcomes remain unclear because of the risk of complications and cancer recurrence. This study investigated the short‐ and long‐term outcomes of SEMS placement for OCRC. Methods and Results: We retrospectively reviewed the clinicopathological data of patients with OCRC who underwent preoperative treatment and tumor resection at our institution between April 2004 and March 2022. Among 113 patients with OCRC, 30 underwent SEMS placement (Group S) and 36 underwent ileus tube insertion (Group T); Group S had more older patients and fewer pT4 cases; no other characteristics differed. Incidence of severe complications was 0% versus 16.7% ( p < 0.01); postoperative hospital stay was 14.3 versus 26.6 days ( p < 0.01); medical costs were comparable between the groups. The long‐term outcomes of Group S and patients with non‐OCRC who underwent surgery during the same period were compared after propensity score matching. The 5‐year survival rates were 69.5% and 77.1%; the 5‐year recurrence‐free survival rates were 44.5% and 55.5%, without significant difference. Conclusion: In conclusion, SEMS placement was more effective than ileus tube placement in treating OCRC.

  • Effect of Monofilament Sutures on Incisional Hernia After Laparoscopic Colorectal Surgery: A Focus on Patients With Umbilical Hernia

    by Hirokazu Tanaka, Masato Kitazawa, Satoshi Nakamura, Yuta Yamamoto, Satoru Miyazaki, Nao Hondo, Masahiro Kataoka, Naoki Ishizaka, Tadaaki Shimizu, Ryohei Miyashita, et al.

    Background/Aim: Incisional hernia (IH) is a common complication of laparoscopic colorectal surgery and is associated with risk factors such as obesity, diabetes, and smoking. Umbilical hernia is recognized as a strong predictor of IH; however, the effect of suture type on the occurrence of IH remains unclear. We aimed to evaluate whether the use of monofilament sutures reduced the incidence of IH, particularly in patients with umbilical hernias. Patients and Methods: This retrospective cohort study included 223 patients who underwent laparoscopic colorectal surgery between January 2013 and December 2022. Patients were divided into two groups based on the type of suture used: Monofilament or multifilament. IH was diagnosed using computed tomography imaging 2 years postoperatively. Univariate and multivariate logistic regression analyses were performed to identify the risk factors for IH. Results: The overall incidence of IH was 20.7% and 13.6% in the multifilament and monofilament groups, respectively (p=0.217). However, in patients with umbilical hernias, IH was significantly more frequent in the multifilament group (41.5%) than in the monofilament group (17.6%) (p=0.0431). In the multivariate analysis, umbilical hernia (odds ratio=3.4, 95% confidence interval=1.69-6.91; ppp=0.012) were identified as independent risk factors for IH. No significant differences in postoperative infection rates were observed between the groups. Conclusion: The use of monofilament sutures may reduce the risk of IH in patients with umbilical hernias, although they do not eliminate the risk entirely. Umbilical hernia remains a stronger predictor of IH than body mass index. Further technical refinements are required to optimize wound-closure strategies and minimize IH occurrence.

  • Open Access

    Utility of High-positioning Pelvic Pads in Laparoscopic Sigmoid Colon and Rectal Surgeries

    by Masato Kitazawa, Satoshi Nakamura, Yuta Yamamoto, Satoru Miyazaki, Nao Hondo, Masahiro Kataoka, Hirokazu Tanaka, Yuji Soejima

    Background/Aim: The increased use of robotic rectal surgery has raised concerns regarding the increase in postoperative complications, e.g., compartment syndrome, associated with factors such as the Trendelenburg position, use of the adjustable lithotomy stirrup, and prolonged surgical duration. Therefore, in this study, we evaluated the utility of high-positioning pelvic pads during laparoscopic rectal and sigmoid colon surgeries, which is employed in our institution to maintain a stable body position with reduced head-down tilt. Patients and Methods: We included patients who underwent laparoscopic sigmoidectomy and rectal resection at Shinshu University Hospital between January 2016 and December 2021. We performed two studies: Study 1 compared the short-term treatment outcomes between patients who used high-positioning pelvic pads during surgery and those who did not, whereas Study 2 analyzed factors affecting the time to inferior mesenteric artery division using multivariate analysis. Results: In Study 1, no significant differences in patient demographics were observed between the groups. The use of high-positioning pelvic pads significantly reduced the overall surgical time and number of gauzes used, with no significant differences in blood loss, complication rates, or duration of hospital stay. In Study 2, we identified intra-abdominal adhesions requiring adhesiolysis and use of high-positioning pelvic pads as factors influencing the time to inferior mesenteric artery division. Conclusion: The use of high-positioning pelvic pads facilitated surgeries with a reduced head-down tilt, thereby contributing to shorter surgical times. This approach may help decrease the incidence of compartment syndrome, suggesting the need for further prospective trials and studies on robotic surgery.


  • Open Access

    A Perivascular Epithelioid Cell Tumor in the Ascending Colon: A Rare Case Involving a Patient With Tuberous Sclerosis

    by Kai Seharada, Masato Kitazawa, Satoshi Nakamura, Yuta Yamamoto, Yuji Soejima

    Tuberous sclerosis (TSC) is a genetic disorder characterized by the development of benign tumors in various organs such as the brain, heart, lungs, kidneys, skin, and gastrointestinal tract. Perivascular epithelioid cell tumors (PEComas) are rare mesenchymal tumors associated with TSC. Primary gastrointestinal PEComas are uncommon. This report describes a PEComa in the ascending colon of a patient with TSC and presents a review of the relevant literature. A 33-year-old female patient with a history of TSC presented with a 30-mm mass in the ascending colon that had remained stable for two years. A colonoscopy revealed a 30-mm submucosal tumor in the ascending colon, and non-neoplastic biopsy results were observed. Contrast-enhanced computed tomography revealed a 30-mm mass in the ascending colon with early contrast enhancement. After considering the differential diagnoses of PEComas, gastrointestinal stromal tumors, and leiomyomas/leiomyosarcomas, laparoscopic ileocecal resection was performed. A white extramural tumor that was covered with a capsule was observed in the ascending colon intraoperatively. The histopathological analysis results suggested a complex array of spindle cells. The immunohistochemistry results for alpha-smooth muscle actin, desmin, and human melanoma black (HMB)-45 were positive, and those for c-kit and S100 were negative, thus confirming the diagnosis of a PEComa. This case highlights the importance of considering PEComas when patients with TSC present with submucosal gastrointestinal tumors and the need for careful diagnostic evaluations of such cases.

  • Open Access

    Laparoscopic Excision of a Tailgut Cyst With Refractory Pain: A Case Report

    by Masato Kitazawa, Seishu Karasawa, Satoshi Nakamura, Yuta Yamamoto, Yuji Soejima

    Tailgut cysts (TGCs) are rare congenital lesions located in the retrorectal space, often remaining asymptomatic and incidentally discovered. However, when symptomatic, they can cause significant discomfort and may require surgical intervention. We report a case of a 40-year-old female who presented with persistent and severe coccygeal pain that significantly impaired her quality of life. Imaging studies revealed a cystic mass consistent with a TGC. Conservative management, including pain control and physical therapy, was ineffective, leading to the decision to surgical treatment. The patient underwent successful laparoscopic excision of the cyst, resulting in complete resolution of symptoms without postoperative complications or recurrence. This case underscores the importance of considering TGCs in the differential diagnosis of chronic coccygeal pain and demonstrates that laparoscopic surgery is a safe and effective treatment option when conservative approaches fail.